These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 21080246
21. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs. Barbano B, Sardo L, Gigante A, Gasperini ML, Liberatori M, Giraldi GD, Lacanna A, Amoroso A, Cianci R. Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726 [Abstract] [Full Text] [Related]
22. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS. Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521 [Abstract] [Full Text] [Related]
24. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature. Hung ML, Lee EW. Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220 [Abstract] [Full Text] [Related]
25. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis]. Ackermann D. Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792 [Abstract] [Full Text] [Related]
29. Ascites: diagnosis and management. Hou W, Sanyal AJ. Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115 [Abstract] [Full Text] [Related]
34. Acute kidney injury and hepatorenal syndrome in cirrhosis. Egerod Israelsen M, Gluud LL, Krag A. J Gastroenterol Hepatol; 2015 Feb 03; 30(2):236-43. PubMed ID: 25160511 [Abstract] [Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome. Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D. Eur J Gastroenterol Hepatol; 2006 Nov 03; 18(11):1143-50. PubMed ID: 17033432 [Abstract] [Full Text] [Related]